| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new dawn for the management of influenza?
|
Tillotson, Glenn S
|
|
|
20 |
10 |
p. 1112-1114
|
artikel
|
| 2 |
Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices
|
MacIntyre, Chandini Raina
|
|
|
20 |
10 |
p. 1105-1106
|
artikel
|
| 3 |
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study
|
Wang, Yang
|
|
|
20 |
10 |
p. 1161-1171
|
artikel
|
| 4 |
Chikungunya vaccine: a single shot for a long protection?
|
Mura, Marie
|
|
|
20 |
10 |
p. 1111-1112
|
artikel
|
| 5 |
Chlamydia pneumoniae mucositis syndrome
|
Mokashi, Vaibhav
|
|
|
20 |
10 |
p. 1216
|
artikel
|
| 6 |
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
|
Principi, Nicola
|
|
|
20 |
10 |
p. 1118
|
artikel
|
| 7 |
Cholera: Zimbabwe's unsung political victim
|
Makoni, Munyaradzi
|
|
|
20 |
10 |
p. 1134
|
artikel
|
| 8 |
Colistin resistance in China: from outer membrane to One Health
|
Perez, Federico
|
|
|
20 |
10 |
p. 1106-1108
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2020; 20: e192–97
|
|
|
|
20 |
10 |
p. e250
|
artikel
|
| 10 |
Correction to Lancet Infect Dis 2020; published online Aug 3. https://doi.org/10.1016/S1473-3099(20)30589-2
|
|
|
|
20 |
10 |
p. e250
|
artikel
|
| 11 |
COVID-19 claims another victim
|
Burki, Talha
|
|
|
20 |
10 |
p. 1129-1130
|
artikel
|
| 12 |
COVID-19 in Africa: half a year later
|
Makoni, Munyaradzi
|
|
|
20 |
10 |
p. 1127
|
artikel
|
| 13 |
Curing COVID-19
|
The Lancet Infectious Diseases,
|
|
|
20 |
10 |
p. 1101
|
artikel
|
| 14 |
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
|
Ison, Michael G
|
|
|
20 |
10 |
p. 1204-1214
|
artikel
|
| 15 |
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study
|
Kucharski, Adam J
|
|
|
20 |
10 |
p. 1151-1160
|
artikel
|
| 16 |
Effect of postoperative continuation of antibiotic prophylaxis on the incidence of surgical site infection: a systematic review and meta-analysis
|
de Jonge, Stijn W
|
|
|
20 |
10 |
p. 1182-1192
|
artikel
|
| 17 |
Evelina Tacconelli—two viruses, two wars
|
Kirby, Tony
|
|
|
20 |
10 |
p. 1132
|
artikel
|
| 18 |
Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study
|
Jing, Qin-Long
|
|
|
20 |
10 |
p. 1141-1150
|
artikel
|
| 19 |
Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2
|
Pitzer, Virginia E
|
|
|
20 |
10 |
p. 1103-1104
|
artikel
|
| 20 |
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
|
Rathi, Sahaj
|
|
|
20 |
10 |
p. 1118-1119
|
artikel
|
| 21 |
Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
|
Tilangi, Praveen
|
|
|
20 |
10 |
p. 1119-1120
|
artikel
|
| 22 |
Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
|
Afra, TP
|
|
|
20 |
10 |
p. 1120-1121
|
artikel
|
| 23 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
20 |
10 |
p. 1130
|
artikel
|
| 24 |
Long-term consequences of COVID-19: research needs
|
Yelin, Dana
|
|
|
20 |
10 |
p. 1115-1117
|
artikel
|
| 25 |
Making decisions to mitigate COVID-19 with limited knowledge
|
Zhang, Weituo
|
|
|
20 |
10 |
p. 1121-1122
|
artikel
|
| 26 |
mcr-1 and plasmid prevalence in Escherichia coli from livestock
|
Liu, Yi-Yun
|
|
|
20 |
10 |
p. 1126
|
artikel
|
| 27 |
Monitoring approaches for health-care workers during the COVID-19 pandemic
|
Bielicki, Julia A
|
|
|
20 |
10 |
p. e261-e267
|
artikel
|
| 28 |
Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential
|
Peeling, Rosanna W
|
|
|
20 |
10 |
p. e268-e273
|
artikel
|
| 29 |
Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study
|
Strich, Jeffrey R
|
|
|
20 |
10 |
p. 1172-1181
|
artikel
|
| 30 |
Pathologists in pursuit of the COVID-19 culprit
|
Yi, Eunhee S
|
|
|
20 |
10 |
p. 1102-1103
|
artikel
|
| 31 |
Persistence of US measles risk due to vaccine hesitancy and outbreaks abroad
|
Gardner, Lauren
|
|
|
20 |
10 |
p. 1114-1115
|
artikel
|
| 32 |
Plea for multitargeted interventions for severe COVID-19
|
Gaborit, Benjamin Jean
|
|
|
20 |
10 |
p. 1122-1123
|
artikel
|
| 33 |
Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA
|
Wells, Chad R
|
|
|
20 |
10 |
p. 1123-1125
|
artikel
|
| 34 |
Protecting workers aged 60–69 years from COVID-19
|
Glynn, Judith R
|
|
|
20 |
10 |
p. 1123
|
artikel
|
| 35 |
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
|
Carsana, Luca
|
|
|
20 |
10 |
p. 1135-1140
|
artikel
|
| 36 |
Purple urine bag syndrome: a colourful complication of urinary tract infection
|
de Menezes Neves, Precil Diego Miranda
|
|
|
20 |
10 |
p. 1215
|
artikel
|
| 37 |
Real-world antibiotic needs for resistant Gram-negative infections
|
Fitzpatrick, Margaret A
|
|
|
20 |
10 |
p. 1108-1109
|
artikel
|
| 38 |
Research brief
|
Devi, Sharmila
|
|
|
20 |
10 |
p. 1131
|
artikel
|
| 39 |
Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial
|
Wressnigg, Nina
|
|
|
20 |
10 |
p. 1193-1203
|
artikel
|
| 40 |
STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies
|
Bharucha, Tehmina
|
|
|
20 |
10 |
p. e251-e260
|
artikel
|
| 41 |
Surgical antibiotic prophylaxis: more is not better
|
Roberts, Sally A
|
|
|
20 |
10 |
p. 1110-1111
|
artikel
|
| 42 |
The arrival of Sputnik V
|
Balakrishnan, Vijay Shankar
|
|
|
20 |
10 |
p. 1128
|
artikel
|
| 43 |
The big disease with a little name
|
Burki, Talha
|
|
|
20 |
10 |
p. 1133
|
artikel
|
| 44 |
Use of polymyxins in Chinese hospitals
|
Zhang, Rong
|
|
|
20 |
10 |
p. 1125-1126
|
artikel
|
| 45 |
Vaccinology: time to change the paradigm?
|
Benn, Christine Stabell
|
|
|
20 |
10 |
p. e274-e283
|
artikel
|
Tijdschrift beschrijving